Kinross, Pete;
Petersen, Andreas;
Skov, Robert;
Van Hauwermeiren, Evelyn;
Pantosti, Annalisa;
Laurent, Frédéric;
Voss, Andreas;
Kluytmans, Jan;
Struelens, Marc J;
Heuer, Ole;
Monnet, Dominique L
Livestock-associated meticillin-resistant Staphylococcus aureus (MRSA) among human MRSA isolates, European Union/European Economic Area countries, 2013
Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
Medientyp:
E-Artikel
Titel:
Livestock-associated meticillin-resistant Staphylococcus aureus (MRSA) among human MRSA isolates, European Union/European Economic Area countries, 2013
Beteiligte:
Kinross, Pete;
Petersen, Andreas;
Skov, Robert;
Van Hauwermeiren, Evelyn;
Pantosti, Annalisa;
Laurent, Frédéric;
Voss, Andreas;
Kluytmans, Jan;
Struelens, Marc J;
Heuer, Ole;
Monnet, Dominique L
Erschienen:
European Centre for Disease Control and Prevention (ECDC), 2017
Erschienen in:Eurosurveillance
Sprache:
Englisch
DOI:
10.2807/1560-7917.es.2017.22.44.16-00696
ISSN:
1560-7917
Entstehung:
Anmerkungen:
Beschreibung:
<jats:p>Currently, surveillance of livestock-associated meticillin-resistant <jats:italic>Staphylococcus aureus</jats:italic> (LA-MRSA) in humans in Europe is not systematic but mainly event-based. In September 2014, the European Centre for Disease Prevention and Control (ECDC) initiated a questionnaire to collect data on the number of LA-MRSA from human samples (one isolate per patient) from national/regional reference laboratories in European Union/European Economic Area (EU/EEA) countries in 2013. Identification of LA-MRSA as clonal complex (CC) 398 by multilocus sequence typing (MLST) was preferred, although surrogate methods such as <jats:italic>spa</jats:italic>-typing were also accepted. The questionnaire was returned by 28 laboratories in 27 EU/EEA countries. Overall, LA-MRSA represented 3.9% of 13,756 typed MRSA human isolates, but it represented ≥ 10% in five countries (Belgium, Denmark, Spain, the Netherlands and Slovenia). Seven of the reference laboratories did not type MRSA isolates in 2013. To monitor the dispersion of LA-MRSA and facilitate targeted control measures, we advocate periodic systematic surveys or integrated multi-sectorial surveillance.</jats:p>